8-99134673-G-T

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_017890.5(VPS13B):​c.1248G>T​(p.Gln416His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00148 in 1,610,354 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. Q416Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0011 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0015 ( 3 hom. )

Consequence

VPS13B
NM_017890.5 missense

Scores

1
11
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:12B:3

Conservation

PhyloP100: 2.41

Publications

9 publications found
Variant links:
Genes affected
VPS13B (HGNC:2183): (vacuolar protein sorting 13 homolog B) This gene encodes a potential transmembrane protein that may function in vesicle-mediated transport and sorting of proteins within the cell. This protein may play a role in the development and the function of the eye, hematological system, and central nervous system. Mutations in this gene have been associated with Cohen syndrome. Multiple splice variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
VPS13B Gene-Disease associations (from GenCC):
  • Cohen syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Myriad Women’s Health, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012536347).
BS2
High Homozygotes in GnomAdExome4 at 3 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
VPS13BNM_017890.5 linkc.1248G>T p.Gln416His missense_variant Exon 9 of 62 ENST00000358544.7 NP_060360.3
VPS13BNM_152564.5 linkc.1248G>T p.Gln416His missense_variant Exon 9 of 62 ENST00000357162.7 NP_689777.3
VPS13BNM_015243.3 linkc.1248G>T p.Gln416His missense_variant Exon 9 of 18 NP_056058.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
VPS13BENST00000358544.7 linkc.1248G>T p.Gln416His missense_variant Exon 9 of 62 1 NM_017890.5 ENSP00000351346.2
VPS13BENST00000357162.7 linkc.1248G>T p.Gln416His missense_variant Exon 9 of 62 1 NM_152564.5 ENSP00000349685.2

Frequencies

GnomAD3 genomes
AF:
0.00108
AC:
164
AN:
152028
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00216
Gnomad ASJ
AF:
0.00403
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00123
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00135
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00120
AC:
301
AN:
250668
AF XY:
0.00117
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.00104
Gnomad ASJ exome
AF:
0.00447
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.00150
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00153
AC:
2227
AN:
1458208
Hom.:
3
Cov.:
30
AF XY:
0.00149
AC XY:
1082
AN XY:
725260
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33424
American (AMR)
AF:
0.00121
AC:
54
AN:
44632
Ashkenazi Jewish (ASJ)
AF:
0.00457
AC:
119
AN:
26044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39452
South Asian (SAS)
AF:
0.000176
AC:
15
AN:
85304
European-Finnish (FIN)
AF:
0.00165
AC:
88
AN:
53276
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5746
European-Non Finnish (NFE)
AF:
0.00166
AC:
1848
AN:
1110088
Other (OTH)
AF:
0.00158
AC:
95
AN:
60242
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
101
201
302
402
503
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
74
148
222
296
370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00108
AC:
164
AN:
152146
Hom.:
0
Cov.:
32
AF XY:
0.00108
AC XY:
80
AN XY:
74376
show subpopulations
African (AFR)
AF:
0.000144
AC:
6
AN:
41546
American (AMR)
AF:
0.00216
AC:
33
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00403
AC:
14
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4820
European-Finnish (FIN)
AF:
0.00123
AC:
13
AN:
10594
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00135
AC:
92
AN:
67918
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00138
Hom.:
2
Bravo
AF:
0.00122
TwinsUK
AF:
0.00243
AC:
9
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00175
AC:
15
ExAC
AF:
0.00124
AC:
151
Asia WGS
AF:
0.000291
AC:
1
AN:
3456

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:12Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cohen syndrome Uncertain:6Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

Mar 20, 2018
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868].

Mar 30, 2021
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

VPS13B NM_152564.4 exon 9 p.Gln416His (c.1248G>T): This variant has not been reported in the literature but is present in 0.4% (45/10348) of Ashkenazi Jewish alleles in the Genome Aggregation Database https://gnomad.broadinstitute.org/variant/8-100146901-G-T). This variant is present in ClinVar (Variation ID:95831). Evolutionary conservation and computational predictive tools suggest that this variant may impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain.

Apr 11, 2022
New York Genome Center
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 26, 2023
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

May 18, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not provided Uncertain:4Benign:1
Dec 20, 2014
Eurofins Ntd Llc (ga)
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Oct 25, 2017
Athena Diagnostics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 21, 2020
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Identified as heterozygous via exome sequencing in a sibling of an individual with autism (Yu et al., 2013); Identified as heterozgyous via exome sequencing for carrier screening for autosomal recessive conditions in a healthy individual (Mehrjoo et al., 2015); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26443248, 23352163)

Dec 05, 2023
Laboratoire de Génétique Moléculaire, CHU Bordeaux
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Nov 03, 2021
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Uncertain:1
Jun 24, 2016
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Inborn genetic diseases Uncertain:1
Jan 30, 2018
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Q416H variant (also known as c.1248G>T), located in coding exon 8 of the VPS13B gene, results from a G to T substitution at nucleotide position 1248. The glutamine at codon 416 is replaced by histidine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

VPS13B-related disorder Benign:1
Sep 02, 2021
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.55
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.020
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0
.;.;T
Eigen
Benign
0.15
Eigen_PC
Benign
0.13
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.93
D;D;D
M_CAP
Uncertain
0.086
D
MetaRNN
Benign
0.013
T;T;T
MetaSVM
Benign
-0.31
T
MutationAssessor
Uncertain
2.4
M;M;M
PhyloP100
2.4
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.0
D;N;N
REVEL
Uncertain
0.49
Sift
Uncertain
0.018
D;D;D
Sift4G
Pathogenic
0.0
D;D;D
Vest4
0.67
ClinPred
0.12
T
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.14
gMVP
0.62
Mutation Taster
=71/29
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143024324; hg19: chr8-100146901; COSMIC: COSV62023777; API